The Prevalence of Depression and Anxiety in Women with Ovarian Cancer: An Updated Systematic Review and Meta-Analysis of Cross-Sectional Studies

Ghamari, Darya; Dehghanbanadaki, Hojat; Khateri, Sorour; Nouri, Elham; Baiezeedi, Sheno; Azami, Mobin; Ezzati Amini, Elnaz; Moradi, Yousef

doi:10.31557/APJCP.2023.24.10.3315

The Prevalence of Depression and Anxiety in Women with Ovarian Cancer: An Updated Systematic Review and Meta-Analysis of Cross-Sectional Studies

Document Type : Systematic Review and Meta-analysis

Authors

¹ Student Research Committee, Kurdistan University of Medical Sciences Sanandaj, Iran.

² Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.

³ Social Determinant of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.

⁴ Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.

10.31557/APJCP.2023.24.10.3315

Abstract

Background: The results of this study included the prevalence of anxiety and depression in women with ovarian cancer. Methods: A thorough search of numerous databases, including PubMed (Medline), Scopus, Web of Science, Embase, and PsycoInfo, was conducted to identify relevant cross-sectional studies published between July 2013 and October 2021. STATA 16 was used to analyses the data, and a random effects model was used to determine the pooled prevalence and a 95% confidence interval (95%CI). Results: Of the 18 cross-sectional studies reviewed, 17 reported the prevalence of anxiety and 16 reported the prevalence of depression in patients with ovarian cancer. There was a moderate degree of heterogeneity between studies, as the pooled prevalence of depression was 27% (95%CI: 14%-41%; I2=69.44%). Similarly, there was a greater degree of heterogeneity in the pooled prevalence of anxiety, which was found to be 33% (95%CI: 21%-44%; I2=78.55%). Conclusion: The findings of this study show that, compared to the overall female population, ovarian cancer patients have much greater rates of sadness and anxiety. These results highlight the necessity for healthcare policymakers to prioritize the provision of resources and support for carrying out additional research, such as longitudinal studies or cohorts, to ascertain the efficacy of various treatments or interventions intended to lessen mental health disorders in women diagnosed with ovarian cancer. Healthcare practitioners can enhance the general wellbeing and quality of life for women with this disease by addressing the psychological components of care.

Keywords